Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A brings 2009 start-up Promethera Biosciences €5.3mm

Executive Summary

Stem cell therapy start-up Promethera Biosciences has raised €5.3mm ($7.9mm) in its Series A financing led by Vesalius Biocapital, which was joined by Société Régionale d'Investissement de Wallonie, Life Sciences Research Partners, NivelInvest, Capital & Croissance, LRM Oxygen for Growth, Vives, business angels, and company founders Professor Etienne Sokal and Sopartec SA.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies